简体中文

Press releases

20 Dec 2024

CORXEL and Sanofi Announce an Agreement for Aficamten in Greater China Markets

Read article
11 Dec 2024

CORXEL Announces Strategic Collaboration Agreement with Grand Pharma

Read article
04 Dec 2024

CORXEL Announces NMPA Acceptance of Priority Review for Aficamten

Read article
02 Dec 2024

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Read article
27 Nov 2024

CORXEL Announces NMPA Approval of New Drug Application for Varenicline Solution Nasal Spray

Read article
22 Nov 2024

CORXEL Announces TFDA Approval of New Drug Application for Varenicline Solution Nasal Spray for the Taiwan Region

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2026 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号